If you are searching rifaximin hepatic encephalopathy, then you may already know that rifaximin is commonly used for treatment of hepatic encephalopathy and has proved to be effective in many cases.
Hepatic encephalopathy, otherwise known as portosystemic encephalopathy, is a disease that causes liver failure. Toxins that are usually filtered by the liver gradually build up in the bloodstream. Toxicity results from incomplete liver function and can lead to coma or even death if untreated. In some cases, treatment can be very effective and even reverse the disease.
Hepatic encephalopathy is treated according to severity. It may be necessary to provide intensive care for severe cases of the disease. A liver transplant may also be necessary to treat advanced hepatic encephalopathy. Mild forms of the disease can be treated with antibiotics and special care such as; changing the diet and treating other underlying diseases. When the disease is detected at an early stage it is more likely that it can be reversed.
Rifaximin is one of the newer antibiotics used in hepatic encephalopathy treatment. It reduces the amount of ammonia-producing bacteria in the body. Ammonia and other intestinal toxins are what cause hepatic encephalopathy and liver failure. Rifaximin has been efficient in many cases for the treatment of the disease. Studies have shown that Rifaximin has reduced the risk of hospitalization due to hepatic encephalopathy, and has been very effective with little or no side effects. It is possible that people taking Rifaximin will experience; lethargy, dizziness, nausea, gas, and headaches. Allergic reactions and more severe side effects have seldom been reported with the use of Rifaximin. Also, unlike other antibiotics, Rifaximin has a low probability of causing bacterial resistance.
People suffering from hepatic encephalopathy find it hard to live with the disease. It can cause a great deal of physical pain and emotional distress often leading to depression. Since Rifaximin was approved by the FDA in 2004, more people have been given hope of recovering from hepatic encephalopathy. It is currently one of the more effective forms of treatment for the disease and has immensely reduced hospitalization stays. It is usually favored as a first choice treatment for less severe forms of hepatic encephalopathy. Rifaximin has the ability to improve a person’s quality of life.
Hepatic encephalopathy is diagnosed with various tests including; blood tests, ultrasound screening, and biopsy of the liver. Most people suffering from a mild form of hepatic encephalopathy are not easily diagnosed. The symptoms may not be present or are not severe enough to be easily detected. People with a mild form of the disease may experience; confusion, poor memory, inability to sleep at night, sleepiness during the day, unexplained irritability, and balance incoordination. A more severe form of hepatic encephalopathy will manifest with more noticeable symptoms. These include; lethargy, increased state of confusion, behavioral changes, seizures, and coma. The general characteristics of liver failure may also be present. These symptoms include; jaundice (yellowing of the skin and the white part of the eyes), accumulation of fluid in the abdomen, fluid accumulation in the skin (especially the legs), and reflex abnormalities.